Sydney Outreach 2010 - Medical Practitioner Program & Patient Assessments

When 2nd May - 11th May 2010
About

Do you or a family member suffer from depression, post-natal depression, schizophrenia, bipolar disorder, alzheimer’s disease, ADD or ADHD, a behaviour disorder or an autism spectrum disorder?

Our team of internationally acclaimed USA doctors visiting Sydney in May 2010 could help change your/their life. Your Doctor will attend the consultation with you and learn how to continue your individualized biochemical treatment program for the best possible outcome.

Where Rydges World Square Hotel, 389 Pitt Street (cnr Liverpool St.), Sydney NSW Australia (See Map)
Organiser Bio-Balance Health Association Inc.
Experts Dr William Walsh, Ph.D. (USA)
Dr Mary Megson, M.D. (USA)
Dr James Neubrander, M.D. (USA)
Dr. Albert Mensah M.D. (USA)
Bookings Marnie Lo, Outreach Co-ordinator Ph: 02 8014 3295
Payments: Bio-Balance: Ph: 07 5515 7142
Cost Patient Assessment Program - $900 AUD
Early Bird concession rate of $750 AUD if the fee is paid before 4th December 2009


Download Outreach 2010 Patient Assessment Brochure

Patient Assessment Program

Medical practitioners trained in Walsh Research Institute assessment and treatment techniques prescribe vitamins, minerals, amino acids and fatty acids based on each patient's unique body chemistry.

Dr Walsh's innovative approach to treating biochemical imbalances has helped thousands of patients from all over the world over the last 20 years. Dr Walsh and his associates have been visiting Australia annually since 2004 to train Australian & New Zealand medical practitioners in these techniques and to assess patients. Dr Walsh is being joined by three outstanding US experts in conducting the 2010 Outreach Patient Assessment and Medical Practitioner Training Program.

Patients and families report that nutritional treatment to correct their biochemical imbalances produces significant improvements in:

  • Attention, Learning & Behaviour Disorders
  • Depression
  • Post-Natal Depression
  • Schizophrenia & Bipolar Disorder
  • Autism Spectrum Disorders
  • Alzheimer's Disease

Dr Walsh, Dr Megson, Dr Neubrander and Dr Mensah are professionals dedicated to helping patients lead a productive and rewarding life.

Prior to the consultation, patients are screened for the presence of biochemical imbalances with a comprehensive medical history, physical examination and laboratory analysis of special blood, urine and hair analysis tests. Based on the findings, an expert assessment is conducted at the consultation and an individualized nutrient program is prescribed to correct the person's biochemical imbalances.

The Outreach Clinic will be held at Rydges World Square Hotel, 389 Pitt St. (cnr Liverpool St.), Sydney from 2nd to 11th May 2010. Rydges World Square Hotel offers Outreach patients accommodation at reduced rates for this Outreach.

The fee for the assessment is $900 AUD, with an Early Bird concession rate of $750 AUD if the fee is paid before 4th December 2009.

NOTE: It is a condition of the assessment that clients agree to allow several doctors who are training at the Outreach to be present during the consultation.

Dr William J Walsh, PhD

Dr William J Walsh, PhD

Dr Walsh is a scientist with over 40 years of research experience. He holds a Doctorate in Chemical Engineering from Iowa State University. Dr. Walsh's volunteer and research work involving biochemical predisposition to violent crime and behavior disorders during his career at Argonne National Laboratory, in collaboration with Dr Carl Pfeiffer, led to him founding the Health Research Institute in 1982 and the Pfeiffer Treatment Center (HRI-PTC) in 1989 in Chicago USA.

He was President of HRI-PTC until 1998 and subsequently Director of Research there until June 2008, when he left to set up the Walsh Research Institute to enable him to concentrate exclusively on research and practitioner training in advanced nutrient therapy methods for mental and behavioural disorders and cutting-edge autism therapies.

During Dr Walsh's time at HRI-PTC, more than 20,000 people from USA, Australia, NZ and more than 70 other countries were treated for these disorders.

Dr Walsh is the author of more than 200 research reports which include:
  • Link between autism and abnormal blood vessel function and oxidative stress
  • Fatty acid profiles of schizophrenic phenotypes
  • Disordered metal metabolism in a large autism population
  • Biochemical therapy and behaviour outcomes
  • With Argonne National Laboratory, identification of lead poisoning as cause of composer Beethoven's illness from samples of Beethoven's hair and bone
  • Elevated copper levels in post-partum depression. Several other research studies are in progress

Dr James A Neubrander, MD

Dr James A Neubrander, MD

Dr Neubrander is a renowned clinician and lecturer from Edison, New Jersey USA where he has had a flourishing private practice since 1997 focused on Autistic Spectrum Disorders, Hyperbaric Oxygen Therapy, Heavy Metal Detoxification, Environmental Medicine, Preventive Medicine, Allergy, Nutritional Medicine, Metabolic and Molecular Medicine.

After completing his MD at Loma Linda University and medical residency at Tampa General Hospital, he was in private practice in environmental and preventive medicine and then Director of the Nutrition Medical Center in Tampa until joining the medical staff of the Carl C. Pfeiffer Institute, Skillman, New Jersey in 1988, where he worked, including a period as Acting Director, until returning to private practice in 1995.

Dr Neubrander is passionately committed to resolving the problems of children with autism spectrum and other neurodevelopmental disorders. His main current interests are Biomedical and Hyperbaric Oxygen treatments for Autism spectrum disorders, ADD, ADHD, Language Delay, Apraxia and Sensory Integration Problems. He has developed numerous protocols based on Biochemical Individuality noted in this subset of the population.

He is continuously researching the most innovative treatment possibilities. In 2002 he discovered the profound effect Methyl-B12 has on Autism and Neurodevelopmental disorders. Since then he has worked with others on developing a sophisticated protocol for the clinical application of Methyl-B12 in these areas. Many parents worldwide have their children on Dr Neubrander's protocol that is very successful. In his practice 94% of children respond to this protocol.

Visit Dr James A Neubrander's Website

Dr Mary N Megson, MD

Dr Mary N Megson, MD

Dr Megson is a developmental pediatrician in private practice in Richmond Virginia USA and also Assistant Professor of Pediatrics at The Medical College of Virginia (Richmond). Mary has worked in the field of Pediatrics for more than twenty years. As a developmental specialist in pediatrics, she devotes her career to children with developmental issues including ADHD, ADD, Autistic Spectrum Disorder, Developmental Delays and Asperger's Syndrome.

Dr Megson's areas of professional interest include Behavioural Pediatrics, Child Development, Adolescent Medicine and Neonatology. Dr Megson is board certified by the American Board of Pediatrics, a Fellow of The American Academy of Pediatrics and a Member of The Society of Developmental Pediatrics. She travels all over the world speaking at international conferences.

Dr Megson's research area is use of Vitamin A and Bethanecol in the treatment of Autistic Spectrum Disorders. She believes that autism is both a neuroimmune and an autoimmune disorder. In her studies of autistic children, she repeatedly found chronic diseases such as celiac disease, rheumatoid arthritis, insulin-dependant diabetes, IGA deficiency, and psoriasis in the family medical histories. She is currently investigating the hypothesis that G-alpha protein defects are a high-risk factor for developing autism after vaccination. Her clinical trial of 60 children suggests that inserting a G-alpha protein defect, the pertussis toxin found in DPT vaccine, into genetically at-risk children may be a cause of autism.

Dr Megson is credited with the largest number of recovered autistic patients in the USA (DAN Conference). Her work with autistic children is featured in the documentary film Beautiful Son.

Dr Albert Mensah, MD

Dr Albert Mensah, MD

Albert Mensah, MD, received his undergraduate degree from Northwestern University (Evanston, Illinois) and his medical degree from Finch University of Health Sciences-Chicago Medical School. Dr. Mensah’s residency was in family medicine at Swedish Covenant Hospital (Chicago). Following residency, he completed additional fellowship training in academic development at JHS Cook County Hospital (Chicago).

Dr. Mensah practiced as a staff physician at Melrose Park Clinic (Illinois) and is an adjunct professor of clinical medicine at Malcolm X College (Chicago). He continues his devotion to the education of medical professionals by serving as the current Medical Director of the Physician Assistant Program at Malcolm X College. Dr. Mensah treated patients at the Pfeiffer Treatment Center, an organization rooted in the treatment of biochemical imbalances including children with autism.

Answering the need for specialist with backgrounds in both traditional as well as orthomolecular medicine, Dr. Mensah cofounded Mensah Medical. His current practice includes family medicine as well as the management of cognitive disorders such as Alzheimer's disease, schizophrenia, depression, bipolar disorder, anxiety syndromes, ADD/H and post-partum depression.

Philosophy of Care: ..."We are not given knowledge to rule over the world for the sake of power, but to have power for the sake of serving. Taking the time to educate our patients, their families, and the healthcare community at large is consistent with our directive to leave the universe a better place than when we came."

Visit Dr Albert Mensah's Website

How to Get There